JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2173405, encodeId=4d7b21e34058f, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：刚被拒稿，一审25天，三个审稿人，意见都很nice，小修，一个半月返修，审稿人建议接收，但是编辑拒稿了，没有具体意见。不知道这是什么操作？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f835700270, createdName=ms9000000525256501, createdTime=Thu Dec 07 00:23:54 CST 2023, time=2023-12-07, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2194513, encodeId=896c219451396, content=有家人们一个月还没找到审稿人的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10fa8295255, createdName=ms5000000501352747, createdTime=Thu Mar 21 17:36:01 CST 2024, time=2024-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2193961, encodeId=a5982193961f4, content=Reviewers Assigned状态已经快一个月了，请问这个正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/32icunDzVeCjOW38wRia5kicJQp9sDKziaKaUsmmpksiaUfzPE7bPujqVS8ESgicLcWJ2mZUJibT8Z8TfK7fzdUTbJia5w/132, createdBy=ad7e1301227, createdName=ilpjing, createdTime=Mon Mar 18 21:49:24 CST 2024, time=2024-03-18, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2228128, encodeId=28bb222812876, content=请问JECCR跟cell reports 哪个更难一点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4c05433377, createdName=ms4000000962704650, createdTime=Sat Sep 28 07:54:44 CST 2024, time=2024-09-28, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2222448, encodeId=7ed92222448b0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤分子生物学 经验分享：目前即时影响因子：7.45分，明年大概率能到12分。在影响因子下滑的时代，能连续多年维持10分以上，相当不容易，尤其是杂志并没有通过一些非常规手段：如，提前大半年发表文章，发表大量letter，发表过高比例的review，发表大量会议摘要，组件青年编委引用团队等，来操纵影响因子。被cancer research, 大CDD，advanced science 等拒了朋友，可以一试，机会很大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Mon Aug 26 13:08:22 CST 2024, time=2024-08-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2222221, encodeId=a28c2222221d3, content=刚中了一篇这个，这杂志对青基作用大不？网上大家好像不是很看好的样子。有申请过的朋友吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18838620417, createdName=ms4000000771872851, createdTime=Sat Aug 24 16:24:01 CST 2024, time=2024-08-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211174, encodeId=ff2022111e4dc, content=此杂志投稿会预印吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=16a16166362, createdName=莹儿飞, createdTime=Sat Jun 22 22:53:25 CST 2024, time=2024-06-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2215516, encodeId=b7aa2215516e4, content=偏重的研究方向：肿瘤;分子机制;肿瘤分子生物学 经验分享：请问大家under review之后都是多久收到审稿意见的啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2485555070, createdName=ms7000001497079241, createdTime=Thu Jul 18 00:02:16 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143088, encodeId=165e214308883, content=偏重的研究方向：肿瘤;分子机制 经验分享：投稿6天reviewers assigned，当天under review。结果3天后又变成了reviewers assigned，请问这是没有找到审稿人吗？大家是否遇到过这种情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJN9OHDrdEGwpniaHlhT7OyAJsScbRwJ4Jauzia9ic9mYAzkGAW87ArL5zdkJzeY5pEgic8vFvdJyGibew/132, createdBy=65bd2215969, createdName=BALALA2, createdTime=Fri Jun 16 09:52:28 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196657, encodeId=0e1e219665ea7, content=under review五天后又变成reviewers assigned了。。这是同意审稿的人又放弃了吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:51:29 CST 2024, time=2024-04-02, status=1, ipAttribution=上海)]

2023-12-07 ms9000000525256501 来自安徽省

审稿速度:1.0 | 投稿命中率:25.0
经验分享：刚被拒稿，一审25天，三个审稿人，意见都很nice，小修，一个半月返修，审稿人建议接收，但是编辑拒稿了，没有具体意见。不知道这是什么操作？

81 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2173405, encodeId=4d7b21e34058f, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：刚被拒稿，一审25天，三个审稿人，意见都很nice，小修，一个半月返修，审稿人建议接收，但是编辑拒稿了，没有具体意见。不知道这是什么操作？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f835700270, createdName=ms9000000525256501, createdTime=Thu Dec 07 00:23:54 CST 2023, time=2023-12-07, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2194513, encodeId=896c219451396, content=有家人们一个月还没找到审稿人的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10fa8295255, createdName=ms5000000501352747, createdTime=Thu Mar 21 17:36:01 CST 2024, time=2024-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2193961, encodeId=a5982193961f4, content=Reviewers Assigned状态已经快一个月了，请问这个正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/32icunDzVeCjOW38wRia5kicJQp9sDKziaKaUsmmpksiaUfzPE7bPujqVS8ESgicLcWJ2mZUJibT8Z8TfK7fzdUTbJia5w/132, createdBy=ad7e1301227, createdName=ilpjing, createdTime=Mon Mar 18 21:49:24 CST 2024, time=2024-03-18, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2228128, encodeId=28bb222812876, content=请问JECCR跟cell reports 哪个更难一点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4c05433377, createdName=ms4000000962704650, createdTime=Sat Sep 28 07:54:44 CST 2024, time=2024-09-28, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2222448, encodeId=7ed92222448b0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤分子生物学 经验分享：目前即时影响因子：7.45分，明年大概率能到12分。在影响因子下滑的时代，能连续多年维持10分以上，相当不容易，尤其是杂志并没有通过一些非常规手段：如，提前大半年发表文章，发表大量letter，发表过高比例的review，发表大量会议摘要，组件青年编委引用团队等，来操纵影响因子。被cancer research, 大CDD，advanced science 等拒了朋友，可以一试，机会很大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Mon Aug 26 13:08:22 CST 2024, time=2024-08-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2222221, encodeId=a28c2222221d3, content=刚中了一篇这个，这杂志对青基作用大不？网上大家好像不是很看好的样子。有申请过的朋友吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18838620417, createdName=ms4000000771872851, createdTime=Sat Aug 24 16:24:01 CST 2024, time=2024-08-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211174, encodeId=ff2022111e4dc, content=此杂志投稿会预印吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=16a16166362, createdName=莹儿飞, createdTime=Sat Jun 22 22:53:25 CST 2024, time=2024-06-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2215516, encodeId=b7aa2215516e4, content=偏重的研究方向：肿瘤;分子机制;肿瘤分子生物学 经验分享：请问大家under review之后都是多久收到审稿意见的啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2485555070, createdName=ms7000001497079241, createdTime=Thu Jul 18 00:02:16 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143088, encodeId=165e214308883, content=偏重的研究方向：肿瘤;分子机制 经验分享：投稿6天reviewers assigned，当天under review。结果3天后又变成了reviewers assigned，请问这是没有找到审稿人吗？大家是否遇到过这种情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJN9OHDrdEGwpniaHlhT7OyAJsScbRwJ4Jauzia9ic9mYAzkGAW87ArL5zdkJzeY5pEgic8vFvdJyGibew/132, createdBy=65bd2215969, createdName=BALALA2, createdTime=Fri Jun 16 09:52:28 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196657, encodeId=0e1e219665ea7, content=under review五天后又变成reviewers assigned了。。这是同意审稿的人又放弃了吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:51:29 CST 2024, time=2024-04-02, status=1, ipAttribution=上海)]

2024-03-21 ms5000000501352747 来自江苏省

有家人们一个月还没找到审稿人的吗

128 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2173405, encodeId=4d7b21e34058f, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：刚被拒稿，一审25天，三个审稿人，意见都很nice，小修，一个半月返修，审稿人建议接收，但是编辑拒稿了，没有具体意见。不知道这是什么操作？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f835700270, createdName=ms9000000525256501, createdTime=Thu Dec 07 00:23:54 CST 2023, time=2023-12-07, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2194513, encodeId=896c219451396, content=有家人们一个月还没找到审稿人的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10fa8295255, createdName=ms5000000501352747, createdTime=Thu Mar 21 17:36:01 CST 2024, time=2024-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2193961, encodeId=a5982193961f4, content=Reviewers Assigned状态已经快一个月了，请问这个正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/32icunDzVeCjOW38wRia5kicJQp9sDKziaKaUsmmpksiaUfzPE7bPujqVS8ESgicLcWJ2mZUJibT8Z8TfK7fzdUTbJia5w/132, createdBy=ad7e1301227, createdName=ilpjing, createdTime=Mon Mar 18 21:49:24 CST 2024, time=2024-03-18, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2228128, encodeId=28bb222812876, content=请问JECCR跟cell reports 哪个更难一点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4c05433377, createdName=ms4000000962704650, createdTime=Sat Sep 28 07:54:44 CST 2024, time=2024-09-28, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2222448, encodeId=7ed92222448b0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤分子生物学 经验分享：目前即时影响因子：7.45分，明年大概率能到12分。在影响因子下滑的时代，能连续多年维持10分以上，相当不容易，尤其是杂志并没有通过一些非常规手段：如，提前大半年发表文章，发表大量letter，发表过高比例的review，发表大量会议摘要，组件青年编委引用团队等，来操纵影响因子。被cancer research, 大CDD，advanced science 等拒了朋友，可以一试，机会很大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Mon Aug 26 13:08:22 CST 2024, time=2024-08-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2222221, encodeId=a28c2222221d3, content=刚中了一篇这个，这杂志对青基作用大不？网上大家好像不是很看好的样子。有申请过的朋友吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18838620417, createdName=ms4000000771872851, createdTime=Sat Aug 24 16:24:01 CST 2024, time=2024-08-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211174, encodeId=ff2022111e4dc, content=此杂志投稿会预印吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=16a16166362, createdName=莹儿飞, createdTime=Sat Jun 22 22:53:25 CST 2024, time=2024-06-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2215516, encodeId=b7aa2215516e4, content=偏重的研究方向：肿瘤;分子机制;肿瘤分子生物学 经验分享：请问大家under review之后都是多久收到审稿意见的啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2485555070, createdName=ms7000001497079241, createdTime=Thu Jul 18 00:02:16 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143088, encodeId=165e214308883, content=偏重的研究方向：肿瘤;分子机制 经验分享：投稿6天reviewers assigned，当天under review。结果3天后又变成了reviewers assigned，请问这是没有找到审稿人吗？大家是否遇到过这种情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJN9OHDrdEGwpniaHlhT7OyAJsScbRwJ4Jauzia9ic9mYAzkGAW87ArL5zdkJzeY5pEgic8vFvdJyGibew/132, createdBy=65bd2215969, createdName=BALALA2, createdTime=Fri Jun 16 09:52:28 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196657, encodeId=0e1e219665ea7, content=under review五天后又变成reviewers assigned了。。这是同意审稿的人又放弃了吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:51:29 CST 2024, time=2024-04-02, status=1, ipAttribution=上海)]

2024-03-18 ilpjing 来自浙江省

Reviewers Assigned状态已经快一个月了，请问这个正常吗

82 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2173405, encodeId=4d7b21e34058f, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：刚被拒稿，一审25天，三个审稿人，意见都很nice，小修，一个半月返修，审稿人建议接收，但是编辑拒稿了，没有具体意见。不知道这是什么操作？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f835700270, createdName=ms9000000525256501, createdTime=Thu Dec 07 00:23:54 CST 2023, time=2023-12-07, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2194513, encodeId=896c219451396, content=有家人们一个月还没找到审稿人的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10fa8295255, createdName=ms5000000501352747, createdTime=Thu Mar 21 17:36:01 CST 2024, time=2024-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2193961, encodeId=a5982193961f4, content=Reviewers Assigned状态已经快一个月了，请问这个正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/32icunDzVeCjOW38wRia5kicJQp9sDKziaKaUsmmpksiaUfzPE7bPujqVS8ESgicLcWJ2mZUJibT8Z8TfK7fzdUTbJia5w/132, createdBy=ad7e1301227, createdName=ilpjing, createdTime=Mon Mar 18 21:49:24 CST 2024, time=2024-03-18, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2228128, encodeId=28bb222812876, content=请问JECCR跟cell reports 哪个更难一点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4c05433377, createdName=ms4000000962704650, createdTime=Sat Sep 28 07:54:44 CST 2024, time=2024-09-28, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2222448, encodeId=7ed92222448b0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤分子生物学 经验分享：目前即时影响因子：7.45分，明年大概率能到12分。在影响因子下滑的时代，能连续多年维持10分以上，相当不容易，尤其是杂志并没有通过一些非常规手段：如，提前大半年发表文章，发表大量letter，发表过高比例的review，发表大量会议摘要，组件青年编委引用团队等，来操纵影响因子。被cancer research, 大CDD，advanced science 等拒了朋友，可以一试，机会很大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Mon Aug 26 13:08:22 CST 2024, time=2024-08-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2222221, encodeId=a28c2222221d3, content=刚中了一篇这个，这杂志对青基作用大不？网上大家好像不是很看好的样子。有申请过的朋友吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18838620417, createdName=ms4000000771872851, createdTime=Sat Aug 24 16:24:01 CST 2024, time=2024-08-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211174, encodeId=ff2022111e4dc, content=此杂志投稿会预印吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=16a16166362, createdName=莹儿飞, createdTime=Sat Jun 22 22:53:25 CST 2024, time=2024-06-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2215516, encodeId=b7aa2215516e4, content=偏重的研究方向：肿瘤;分子机制;肿瘤分子生物学 经验分享：请问大家under review之后都是多久收到审稿意见的啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2485555070, createdName=ms7000001497079241, createdTime=Thu Jul 18 00:02:16 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143088, encodeId=165e214308883, content=偏重的研究方向：肿瘤;分子机制 经验分享：投稿6天reviewers assigned，当天under review。结果3天后又变成了reviewers assigned，请问这是没有找到审稿人吗？大家是否遇到过这种情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJN9OHDrdEGwpniaHlhT7OyAJsScbRwJ4Jauzia9ic9mYAzkGAW87ArL5zdkJzeY5pEgic8vFvdJyGibew/132, createdBy=65bd2215969, createdName=BALALA2, createdTime=Fri Jun 16 09:52:28 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196657, encodeId=0e1e219665ea7, content=under review五天后又变成reviewers assigned了。。这是同意审稿的人又放弃了吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:51:29 CST 2024, time=2024-04-02, status=1, ipAttribution=上海)]

2024-09-28 ms4000000962704650 来自江西省

请问JECCR跟cell reports 哪个更难一点。

53 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2173405, encodeId=4d7b21e34058f, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：刚被拒稿，一审25天，三个审稿人，意见都很nice，小修，一个半月返修，审稿人建议接收，但是编辑拒稿了，没有具体意见。不知道这是什么操作？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f835700270, createdName=ms9000000525256501, createdTime=Thu Dec 07 00:23:54 CST 2023, time=2023-12-07, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2194513, encodeId=896c219451396, content=有家人们一个月还没找到审稿人的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10fa8295255, createdName=ms5000000501352747, createdTime=Thu Mar 21 17:36:01 CST 2024, time=2024-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2193961, encodeId=a5982193961f4, content=Reviewers Assigned状态已经快一个月了，请问这个正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/32icunDzVeCjOW38wRia5kicJQp9sDKziaKaUsmmpksiaUfzPE7bPujqVS8ESgicLcWJ2mZUJibT8Z8TfK7fzdUTbJia5w/132, createdBy=ad7e1301227, createdName=ilpjing, createdTime=Mon Mar 18 21:49:24 CST 2024, time=2024-03-18, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2228128, encodeId=28bb222812876, content=请问JECCR跟cell reports 哪个更难一点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4c05433377, createdName=ms4000000962704650, createdTime=Sat Sep 28 07:54:44 CST 2024, time=2024-09-28, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2222448, encodeId=7ed92222448b0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤分子生物学 经验分享：目前即时影响因子：7.45分，明年大概率能到12分。在影响因子下滑的时代，能连续多年维持10分以上，相当不容易，尤其是杂志并没有通过一些非常规手段：如，提前大半年发表文章，发表大量letter，发表过高比例的review，发表大量会议摘要，组件青年编委引用团队等，来操纵影响因子。被cancer research, 大CDD，advanced science 等拒了朋友，可以一试，机会很大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Mon Aug 26 13:08:22 CST 2024, time=2024-08-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2222221, encodeId=a28c2222221d3, content=刚中了一篇这个，这杂志对青基作用大不？网上大家好像不是很看好的样子。有申请过的朋友吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18838620417, createdName=ms4000000771872851, createdTime=Sat Aug 24 16:24:01 CST 2024, time=2024-08-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211174, encodeId=ff2022111e4dc, content=此杂志投稿会预印吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=16a16166362, createdName=莹儿飞, createdTime=Sat Jun 22 22:53:25 CST 2024, time=2024-06-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2215516, encodeId=b7aa2215516e4, content=偏重的研究方向：肿瘤;分子机制;肿瘤分子生物学 经验分享：请问大家under review之后都是多久收到审稿意见的啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2485555070, createdName=ms7000001497079241, createdTime=Thu Jul 18 00:02:16 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143088, encodeId=165e214308883, content=偏重的研究方向：肿瘤;分子机制 经验分享：投稿6天reviewers assigned，当天under review。结果3天后又变成了reviewers assigned，请问这是没有找到审稿人吗？大家是否遇到过这种情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJN9OHDrdEGwpniaHlhT7OyAJsScbRwJ4Jauzia9ic9mYAzkGAW87ArL5zdkJzeY5pEgic8vFvdJyGibew/132, createdBy=65bd2215969, createdName=BALALA2, createdTime=Fri Jun 16 09:52:28 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196657, encodeId=0e1e219665ea7, content=under review五天后又变成reviewers assigned了。。这是同意审稿的人又放弃了吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:51:29 CST 2024, time=2024-04-02, status=1, ipAttribution=上海)]

2024-08-26 1811e984f8m 来自安徽省

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：肿瘤分子生物学
经验分享：目前即时影响因子：7.45分，明年大概率能到12分。在影响因子下滑的时代，能连续多年维持10分以上，相当不容易，尤其是杂志并没有通过一些非常规手段：如，提前大半年发表文章，发表大量letter，发表过高比例的review，发表大量会议摘要，组件青年编委引用团队等，来操纵影响因子。被cancer research, 大CDD，advanced science 等拒了朋友，可以一试，机会很大。

103 0

[GetPortalCommentsPageByObjectIdResponse(id=2173405, encodeId=4d7b21e34058f, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：刚被拒稿，一审25天，三个审稿人，意见都很nice，小修，一个半月返修，审稿人建议接收，但是编辑拒稿了，没有具体意见。不知道这是什么操作？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f835700270, createdName=ms9000000525256501, createdTime=Thu Dec 07 00:23:54 CST 2023, time=2023-12-07, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2194513, encodeId=896c219451396, content=有家人们一个月还没找到审稿人的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10fa8295255, createdName=ms5000000501352747, createdTime=Thu Mar 21 17:36:01 CST 2024, time=2024-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2193961, encodeId=a5982193961f4, content=Reviewers Assigned状态已经快一个月了，请问这个正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/32icunDzVeCjOW38wRia5kicJQp9sDKziaKaUsmmpksiaUfzPE7bPujqVS8ESgicLcWJ2mZUJibT8Z8TfK7fzdUTbJia5w/132, createdBy=ad7e1301227, createdName=ilpjing, createdTime=Mon Mar 18 21:49:24 CST 2024, time=2024-03-18, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2228128, encodeId=28bb222812876, content=请问JECCR跟cell reports 哪个更难一点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4c05433377, createdName=ms4000000962704650, createdTime=Sat Sep 28 07:54:44 CST 2024, time=2024-09-28, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2222448, encodeId=7ed92222448b0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤分子生物学 经验分享：目前即时影响因子：7.45分，明年大概率能到12分。在影响因子下滑的时代，能连续多年维持10分以上，相当不容易，尤其是杂志并没有通过一些非常规手段：如，提前大半年发表文章，发表大量letter，发表过高比例的review，发表大量会议摘要，组件青年编委引用团队等，来操纵影响因子。被cancer research, 大CDD，advanced science 等拒了朋友，可以一试，机会很大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Mon Aug 26 13:08:22 CST 2024, time=2024-08-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2222221, encodeId=a28c2222221d3, content=刚中了一篇这个，这杂志对青基作用大不？网上大家好像不是很看好的样子。有申请过的朋友吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18838620417, createdName=ms4000000771872851, createdTime=Sat Aug 24 16:24:01 CST 2024, time=2024-08-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211174, encodeId=ff2022111e4dc, content=此杂志投稿会预印吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=16a16166362, createdName=莹儿飞, createdTime=Sat Jun 22 22:53:25 CST 2024, time=2024-06-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2215516, encodeId=b7aa2215516e4, content=偏重的研究方向：肿瘤;分子机制;肿瘤分子生物学 经验分享：请问大家under review之后都是多久收到审稿意见的啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2485555070, createdName=ms7000001497079241, createdTime=Thu Jul 18 00:02:16 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143088, encodeId=165e214308883, content=偏重的研究方向：肿瘤;分子机制 经验分享：投稿6天reviewers assigned，当天under review。结果3天后又变成了reviewers assigned，请问这是没有找到审稿人吗？大家是否遇到过这种情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJN9OHDrdEGwpniaHlhT7OyAJsScbRwJ4Jauzia9ic9mYAzkGAW87ArL5zdkJzeY5pEgic8vFvdJyGibew/132, createdBy=65bd2215969, createdName=BALALA2, createdTime=Fri Jun 16 09:52:28 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196657, encodeId=0e1e219665ea7, content=under review五天后又变成reviewers assigned了。。这是同意审稿的人又放弃了吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:51:29 CST 2024, time=2024-04-02, status=1, ipAttribution=上海)]

2024-08-24 ms4000000771872851 来自上海

刚中了一篇这个，这杂志对青基作用大不？网上大家好像不是很看好的样子。有申请过的朋友吗？

75 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2173405, encodeId=4d7b21e34058f, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：刚被拒稿，一审25天，三个审稿人，意见都很nice，小修，一个半月返修，审稿人建议接收，但是编辑拒稿了，没有具体意见。不知道这是什么操作？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f835700270, createdName=ms9000000525256501, createdTime=Thu Dec 07 00:23:54 CST 2023, time=2023-12-07, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2194513, encodeId=896c219451396, content=有家人们一个月还没找到审稿人的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10fa8295255, createdName=ms5000000501352747, createdTime=Thu Mar 21 17:36:01 CST 2024, time=2024-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2193961, encodeId=a5982193961f4, content=Reviewers Assigned状态已经快一个月了，请问这个正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/32icunDzVeCjOW38wRia5kicJQp9sDKziaKaUsmmpksiaUfzPE7bPujqVS8ESgicLcWJ2mZUJibT8Z8TfK7fzdUTbJia5w/132, createdBy=ad7e1301227, createdName=ilpjing, createdTime=Mon Mar 18 21:49:24 CST 2024, time=2024-03-18, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2228128, encodeId=28bb222812876, content=请问JECCR跟cell reports 哪个更难一点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4c05433377, createdName=ms4000000962704650, createdTime=Sat Sep 28 07:54:44 CST 2024, time=2024-09-28, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2222448, encodeId=7ed92222448b0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤分子生物学 经验分享：目前即时影响因子：7.45分，明年大概率能到12分。在影响因子下滑的时代，能连续多年维持10分以上，相当不容易，尤其是杂志并没有通过一些非常规手段：如，提前大半年发表文章，发表大量letter，发表过高比例的review，发表大量会议摘要，组件青年编委引用团队等，来操纵影响因子。被cancer research, 大CDD，advanced science 等拒了朋友，可以一试，机会很大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Mon Aug 26 13:08:22 CST 2024, time=2024-08-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2222221, encodeId=a28c2222221d3, content=刚中了一篇这个，这杂志对青基作用大不？网上大家好像不是很看好的样子。有申请过的朋友吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18838620417, createdName=ms4000000771872851, createdTime=Sat Aug 24 16:24:01 CST 2024, time=2024-08-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211174, encodeId=ff2022111e4dc, content=此杂志投稿会预印吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=16a16166362, createdName=莹儿飞, createdTime=Sat Jun 22 22:53:25 CST 2024, time=2024-06-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2215516, encodeId=b7aa2215516e4, content=偏重的研究方向：肿瘤;分子机制;肿瘤分子生物学 经验分享：请问大家under review之后都是多久收到审稿意见的啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2485555070, createdName=ms7000001497079241, createdTime=Thu Jul 18 00:02:16 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143088, encodeId=165e214308883, content=偏重的研究方向：肿瘤;分子机制 经验分享：投稿6天reviewers assigned，当天under review。结果3天后又变成了reviewers assigned，请问这是没有找到审稿人吗？大家是否遇到过这种情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJN9OHDrdEGwpniaHlhT7OyAJsScbRwJ4Jauzia9ic9mYAzkGAW87ArL5zdkJzeY5pEgic8vFvdJyGibew/132, createdBy=65bd2215969, createdName=BALALA2, createdTime=Fri Jun 16 09:52:28 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196657, encodeId=0e1e219665ea7, content=under review五天后又变成reviewers assigned了。。这是同意审稿的人又放弃了吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:51:29 CST 2024, time=2024-04-02, status=1, ipAttribution=上海)]

2024-06-22 莹儿飞来自贵州省

此杂志投稿会预印吗？

106 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2173405, encodeId=4d7b21e34058f, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：刚被拒稿，一审25天，三个审稿人，意见都很nice，小修，一个半月返修，审稿人建议接收，但是编辑拒稿了，没有具体意见。不知道这是什么操作？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f835700270, createdName=ms9000000525256501, createdTime=Thu Dec 07 00:23:54 CST 2023, time=2023-12-07, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2194513, encodeId=896c219451396, content=有家人们一个月还没找到审稿人的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10fa8295255, createdName=ms5000000501352747, createdTime=Thu Mar 21 17:36:01 CST 2024, time=2024-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2193961, encodeId=a5982193961f4, content=Reviewers Assigned状态已经快一个月了，请问这个正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/32icunDzVeCjOW38wRia5kicJQp9sDKziaKaUsmmpksiaUfzPE7bPujqVS8ESgicLcWJ2mZUJibT8Z8TfK7fzdUTbJia5w/132, createdBy=ad7e1301227, createdName=ilpjing, createdTime=Mon Mar 18 21:49:24 CST 2024, time=2024-03-18, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2228128, encodeId=28bb222812876, content=请问JECCR跟cell reports 哪个更难一点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4c05433377, createdName=ms4000000962704650, createdTime=Sat Sep 28 07:54:44 CST 2024, time=2024-09-28, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2222448, encodeId=7ed92222448b0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤分子生物学 经验分享：目前即时影响因子：7.45分，明年大概率能到12分。在影响因子下滑的时代，能连续多年维持10分以上，相当不容易，尤其是杂志并没有通过一些非常规手段：如，提前大半年发表文章，发表大量letter，发表过高比例的review，发表大量会议摘要，组件青年编委引用团队等，来操纵影响因子。被cancer research, 大CDD，advanced science 等拒了朋友，可以一试，机会很大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Mon Aug 26 13:08:22 CST 2024, time=2024-08-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2222221, encodeId=a28c2222221d3, content=刚中了一篇这个，这杂志对青基作用大不？网上大家好像不是很看好的样子。有申请过的朋友吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18838620417, createdName=ms4000000771872851, createdTime=Sat Aug 24 16:24:01 CST 2024, time=2024-08-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211174, encodeId=ff2022111e4dc, content=此杂志投稿会预印吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=16a16166362, createdName=莹儿飞, createdTime=Sat Jun 22 22:53:25 CST 2024, time=2024-06-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2215516, encodeId=b7aa2215516e4, content=偏重的研究方向：肿瘤;分子机制;肿瘤分子生物学 经验分享：请问大家under review之后都是多久收到审稿意见的啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2485555070, createdName=ms7000001497079241, createdTime=Thu Jul 18 00:02:16 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143088, encodeId=165e214308883, content=偏重的研究方向：肿瘤;分子机制 经验分享：投稿6天reviewers assigned，当天under review。结果3天后又变成了reviewers assigned，请问这是没有找到审稿人吗？大家是否遇到过这种情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJN9OHDrdEGwpniaHlhT7OyAJsScbRwJ4Jauzia9ic9mYAzkGAW87ArL5zdkJzeY5pEgic8vFvdJyGibew/132, createdBy=65bd2215969, createdName=BALALA2, createdTime=Fri Jun 16 09:52:28 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196657, encodeId=0e1e219665ea7, content=under review五天后又变成reviewers assigned了。。这是同意审稿的人又放弃了吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:51:29 CST 2024, time=2024-04-02, status=1, ipAttribution=上海)]

2024-07-18 ms7000001497079241 来自江苏省

偏重的研究方向：肿瘤;分子机制;肿瘤分子生物学
经验分享：请问大家under review之后都是多久收到审稿意见的啊？

94 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2173405, encodeId=4d7b21e34058f, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：刚被拒稿，一审25天，三个审稿人，意见都很nice，小修，一个半月返修，审稿人建议接收，但是编辑拒稿了，没有具体意见。不知道这是什么操作？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f835700270, createdName=ms9000000525256501, createdTime=Thu Dec 07 00:23:54 CST 2023, time=2023-12-07, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2194513, encodeId=896c219451396, content=有家人们一个月还没找到审稿人的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10fa8295255, createdName=ms5000000501352747, createdTime=Thu Mar 21 17:36:01 CST 2024, time=2024-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2193961, encodeId=a5982193961f4, content=Reviewers Assigned状态已经快一个月了，请问这个正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/32icunDzVeCjOW38wRia5kicJQp9sDKziaKaUsmmpksiaUfzPE7bPujqVS8ESgicLcWJ2mZUJibT8Z8TfK7fzdUTbJia5w/132, createdBy=ad7e1301227, createdName=ilpjing, createdTime=Mon Mar 18 21:49:24 CST 2024, time=2024-03-18, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2228128, encodeId=28bb222812876, content=请问JECCR跟cell reports 哪个更难一点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4c05433377, createdName=ms4000000962704650, createdTime=Sat Sep 28 07:54:44 CST 2024, time=2024-09-28, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2222448, encodeId=7ed92222448b0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤分子生物学 经验分享：目前即时影响因子：7.45分，明年大概率能到12分。在影响因子下滑的时代，能连续多年维持10分以上，相当不容易，尤其是杂志并没有通过一些非常规手段：如，提前大半年发表文章，发表大量letter，发表过高比例的review，发表大量会议摘要，组件青年编委引用团队等，来操纵影响因子。被cancer research, 大CDD，advanced science 等拒了朋友，可以一试，机会很大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Mon Aug 26 13:08:22 CST 2024, time=2024-08-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2222221, encodeId=a28c2222221d3, content=刚中了一篇这个，这杂志对青基作用大不？网上大家好像不是很看好的样子。有申请过的朋友吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18838620417, createdName=ms4000000771872851, createdTime=Sat Aug 24 16:24:01 CST 2024, time=2024-08-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211174, encodeId=ff2022111e4dc, content=此杂志投稿会预印吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=16a16166362, createdName=莹儿飞, createdTime=Sat Jun 22 22:53:25 CST 2024, time=2024-06-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2215516, encodeId=b7aa2215516e4, content=偏重的研究方向：肿瘤;分子机制;肿瘤分子生物学 经验分享：请问大家under review之后都是多久收到审稿意见的啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2485555070, createdName=ms7000001497079241, createdTime=Thu Jul 18 00:02:16 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143088, encodeId=165e214308883, content=偏重的研究方向：肿瘤;分子机制 经验分享：投稿6天reviewers assigned，当天under review。结果3天后又变成了reviewers assigned，请问这是没有找到审稿人吗？大家是否遇到过这种情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJN9OHDrdEGwpniaHlhT7OyAJsScbRwJ4Jauzia9ic9mYAzkGAW87ArL5zdkJzeY5pEgic8vFvdJyGibew/132, createdBy=65bd2215969, createdName=BALALA2, createdTime=Fri Jun 16 09:52:28 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196657, encodeId=0e1e219665ea7, content=under review五天后又变成reviewers assigned了。。这是同意审稿的人又放弃了吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:51:29 CST 2024, time=2024-04-02, status=1, ipAttribution=上海)]

2023-06-16 BALALA2 来自北京

偏重的研究方向：肿瘤;分子机制
经验分享：投稿6天reviewers assigned，当天under review。结果3天后又变成了reviewers assigned，请问这是没有找到审稿人吗？大家是否遇到过这种情况？

199 13

展开13条回复

[GetPortalCommentsPageByObjectIdResponse(id=2173405, encodeId=4d7b21e34058f, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：刚被拒稿，一审25天，三个审稿人，意见都很nice，小修，一个半月返修，审稿人建议接收，但是编辑拒稿了，没有具体意见。不知道这是什么操作？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f835700270, createdName=ms9000000525256501, createdTime=Thu Dec 07 00:23:54 CST 2023, time=2023-12-07, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2194513, encodeId=896c219451396, content=有家人们一个月还没找到审稿人的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10fa8295255, createdName=ms5000000501352747, createdTime=Thu Mar 21 17:36:01 CST 2024, time=2024-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2193961, encodeId=a5982193961f4, content=Reviewers Assigned状态已经快一个月了，请问这个正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/32icunDzVeCjOW38wRia5kicJQp9sDKziaKaUsmmpksiaUfzPE7bPujqVS8ESgicLcWJ2mZUJibT8Z8TfK7fzdUTbJia5w/132, createdBy=ad7e1301227, createdName=ilpjing, createdTime=Mon Mar 18 21:49:24 CST 2024, time=2024-03-18, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2228128, encodeId=28bb222812876, content=请问JECCR跟cell reports 哪个更难一点。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4c05433377, createdName=ms4000000962704650, createdTime=Sat Sep 28 07:54:44 CST 2024, time=2024-09-28, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2222448, encodeId=7ed92222448b0, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤分子生物学 经验分享：目前即时影响因子：7.45分，明年大概率能到12分。在影响因子下滑的时代，能连续多年维持10分以上，相当不容易，尤其是杂志并没有通过一些非常规手段：如，提前大半年发表文章，发表大量letter，发表过高比例的review，发表大量会议摘要，组件青年编委引用团队等，来操纵影响因子。被cancer research, 大CDD，advanced science 等拒了朋友，可以一试，机会很大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Mon Aug 26 13:08:22 CST 2024, time=2024-08-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2222221, encodeId=a28c2222221d3, content=刚中了一篇这个，这杂志对青基作用大不？网上大家好像不是很看好的样子。有申请过的朋友吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18838620417, createdName=ms4000000771872851, createdTime=Sat Aug 24 16:24:01 CST 2024, time=2024-08-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211174, encodeId=ff2022111e4dc, content=此杂志投稿会预印吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=16a16166362, createdName=莹儿飞, createdTime=Sat Jun 22 22:53:25 CST 2024, time=2024-06-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2215516, encodeId=b7aa2215516e4, content=偏重的研究方向：肿瘤;分子机制;肿瘤分子生物学 经验分享：请问大家under review之后都是多久收到审稿意见的啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2485555070, createdName=ms7000001497079241, createdTime=Thu Jul 18 00:02:16 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143088, encodeId=165e214308883, content=偏重的研究方向：肿瘤;分子机制 经验分享：投稿6天reviewers assigned，当天under review。结果3天后又变成了reviewers assigned，请问这是没有找到审稿人吗？大家是否遇到过这种情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJN9OHDrdEGwpniaHlhT7OyAJsScbRwJ4Jauzia9ic9mYAzkGAW87ArL5zdkJzeY5pEgic8vFvdJyGibew/132, createdBy=65bd2215969, createdName=BALALA2, createdTime=Fri Jun 16 09:52:28 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196657, encodeId=0e1e219665ea7, content=under review五天后又变成reviewers assigned了。。这是同意审稿的人又放弃了吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:51:29 CST 2024, time=2024-04-02, status=1, ipAttribution=上海)]

2024-04-02 ms5000001046348584 来自上海

under review五天后又变成reviewers assigned了。。这是同意审稿的人又放弃了吗。。

106 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务